Frontiers in Immunology (Feb 2024)

Systemic immune-inflammation Index is associated with chronic kidney disease in the U.S. population: insights from NHANES 2007–2018

  • Xiaoxin Liu,
  • Xinyu Li,
  • Yulin Chen,
  • Xiaoyu Liu,
  • Yanyan Liu,
  • Haotian Wei,
  • Ningxu Li

DOI
https://doi.org/10.3389/fimmu.2024.1331610
Journal volume & issue
Vol. 15

Abstract

Read online

ObjectivesThe systemic immune-inflammation index (SII), a novel and systematic inflammatory biomarker that is associated with chronic kidney disease (CKD), has not received much attention. This study aimed to investigate the relationship between SII and CKD in the United States (U.S.) population.MethodsOur study ultimately included a nationally representative sample of 10,787 adults who participated in the 2007-2018 National Health and Nutrition Examination Survey. Weighted multivariate logistic regression was used to assess the correlation between SII and CKD, and a restricted cubic spline (RCS) model was subsequently used to explore the non-linear relationship between SII and CKD. Subgroup analyses were performed to further the effects of other covariates on the relationship between SII and CKD.ResultsFollowing confounder adjustment, a higher SII was related to the incidence of CKD (OR =1.36; 95% CI, 1.07–1.73; p =0.01), as validated by multivariable logistic regression. The RCS curve revealed a non-linear positive correlation between SII/1000 and CKD incidence (p for non-linear =0.0206). Additionally, subgroup analysis confirmed a stronger correlation for male participants (OR =2.628; 95% CI, 1.829-3.776) than for female participants (OR =1.733; 95% CI, 1.379-2.178) (p for interaction =0.046).ConclusionsSII is positively associated with the incidence of CKD among U.S. adults, especially in males. However, further studies are needed to confirm our findings and explore the causal factors that can contribute to the prevention and treatment of CKD.

Keywords